Cargando…
The implications of pharmacogenomics in oncology
Autor principal: | Latimer, Jean J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tabriz University of Medical Sciences (TUOMS Publishing Group)
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10329749/ https://www.ncbi.nlm.nih.gov/pubmed/37431482 http://dx.doi.org/10.34172/bi.2023.27686 |
Ejemplares similares
-
Current challenges and opportunities for pharmacogenomics: perspective of the Industry Pharmacogenomics Working Group (I-PWG)
por: Bienfait, Karina, et al.
Publicado: (2021) -
Population Pharmacogenomics for Health Equity
por: Jordan, I. King, et al.
Publicado: (2023) -
Integrating epigenomics into pharmacogenomic studies
por: Zhang, Wei, et al.
Publicado: (2008) -
Emerging strategies and applications of pharmacogenomics
por: Milos, Patrice M, et al.
Publicado: (2004) -
Relevance of Pharmacogenomics to the Safe Use of Antimicrobials
por: Daly, Ann K.
Publicado: (2023)